CME Group Inc. : The comeback of an upward trend can be anticipated
Entry price | Target | Stop-loss | Potential |
---|
$179.87 |
$219 |
$167 |
+21.75% |
---|
CME Group Inc. shares could get back into a rising trend over the medium term, as suggested by technical indicators.
Strengths● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● Historically, the company has been releasing figures that are above expectations.
● Sales forecast by analysts have been recently revised upwards.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Weaknesses● Based on current prices, the company has particularly high valuation levels.
● The firm trades with high earnings multiples: 24.9 times its 2020 earnings per share.
● The underlying tendency is negative on the weekly chart below the resistance at 186.11 USD
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Surperformance is Buy on CME GROUP INC. since 2024-03-12
.